Long-term complete remission with Ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients

BACKGROUND: Prostate cancer is one of the most common cancers in men and the fourth leading cause of cancer mortality worldwide. Although major progress has been achieved in the last years for patients with metastatic castrate-resistant prostate cancer (mCRPC), thanks to next-generation androgen rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabel, Luc, Loir, Elika, Gravis, Gwenaelle, Lavaud, Pernelle, Massard, Christophe, Albiges, Laurence, Baciarello, Giulia, Loriot, Yohann, Fizazi, Karim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394619/
https://www.ncbi.nlm.nih.gov/pubmed/28428880
http://dx.doi.org/10.1186/s40425-017-0232-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5394619/
https://www.ncbi.nlm.nih.gov/pubmed/28428880
http://dx.doi.org/10.1186/s40425-017-0232-7

Ejemplares similares